Insider · CIK 0001376854

Amouyal Philippe

Reports to the SEC for 4 companies · WASHINGTON, DC

sec.gov

Transactions

Companies

Filings

CIK

0001376854

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-22	CAVACAVA GROUP, INC.A Award	Director	AAward	+1,881 sh	—	—	19,955
2026-06-03	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−89.3K sh	—	—	0
2026-06-03	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+89.3K sh	—	—	374,486
2026-05-01	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+43.5K sh	—	—	43,478
2026-05-01	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+35.7K sh	—	—	35,714
2025-06-20	CAVACAVA GROUP, INC.A Award	Director	AAward	+1,767 sh	—	—	18,074
2025-06-03	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+104K sh	—	—	103,806
2025-06-03	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+89.3K sh	—	—	89,312
2025-05-13	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+36.8K sh	—	—	285,174
2025-05-13	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−36.8K sh	—	—	0
2024-06-20	CAVACAVA GROUP, INC.A Award	Director	AAward	+1,307 sh	—	—	16,307
2024-05-13	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+36.8K sh	—	—	36,810
2024-05-13	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+44.9K sh	—	—	44,906
2024-04-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+8,032 sh	—	—	248,364
2024-04-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,032 sh	—	—	0
2023-11-17	CAVACAVA GROUP, INC.P Purchase	Director	PPurchase	+10K sh	$33.18	+$332K	15,000
2023-11-13	LXRXLEXICON PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+200K sh	$1.01	+$202K	240,332
2023-06-20	CAVACAVA GROUP, INC.A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-05-21	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+9,302 sh	—	—	40,332
2023-05-21	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,302 sh	—	—	0
2023-04-28	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+12.7K sh	—	—	12,658
2023-04-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+8,032 sh	—	—	8,032
2022-05-21	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+9,302 sh	—	—	9,302
2022-05-21	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+14.4K sh	—	—	14,402
2022-04-30	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,024 sh	—	—	0
2022-04-30	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,024 sh	—	—	31,030
2021-04-30	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,475 sh	—	—	6,475
2021-04-30	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,024 sh	—	—	4,024
2021-04-24	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−10.6K sh	—	—	0
2021-04-24	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10.6K sh	—	—	27,006
2020-04-26	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,466 sh	—	—	16,368
2020-04-26	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,466 sh	—	—	0
2020-04-24	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,115
2020-04-24	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+10.6K sh	—	—	10,638
2019-04-26	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,466 sh	—	—	3,466
2019-04-26	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,519 sh	—	—	6,519
2019-01-02	WWWW INTERNATIONAL, INC.A Award	Director	AAward	+453 sh	—	—	47,484
2018-10-01	WWWW INTERNATIONAL, INC.A Award	Director	AAward	+262 sh	—	—	47,031
2018-08-31	WWWW INTERNATIONAL, INC.S Sale	Director	SSale	−7,500 sh	$75.59	−$567K	46,769
2018-08-31	WWWW INTERNATIONAL, INC.G Gift	Director	GGift	−7,500 sh	—	—	54,269
2018-07-02	WWWW INTERNATIONAL, INC.A Award	Director	AAward	+187 sh	—	—	61,769
2018-04-27	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,857 sh	—	—	2,857
2018-04-27	LXRXLEXICON PHARMACEUTICALS, INC.A Award	Director	AAward	+2,564 sh	—	—	12,902
2018-04-24	Blue Buffalo Pet Products, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−10.6K sh	—	—	0
2018-04-02	WWWW INTERNATIONAL, INC.A Award	Director	AAward	+295 sh	—	—	61,582
2018-01-02	WWWW INTERNATIONAL, INC.A Award	Director	AAward	+390 sh	—	—	61,287
2017-10-02	WWWW INTERNATIONAL, INC.A Award	Director	AAward	+435 sh	—	—	60,897
2017-07-03	WWWW INTERNATIONAL, INC.A Award	Director	AAward	+569 sh	—	—	60,462
2017-04-28	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,857 sh	—	—	2,857
2017-04-28	LXRXLEXICON PHARMACEUTICALS, INC.A Award	Director	AAward	+1,281 sh	—	—	10,338

Recent filings

Accepted (ET)
Jun 244
Amouyal Philippe0001628280-26-045156
SEC(opens sec.gov)
Jun 44
Amouyal Philippe0001062822-26-000103
SEC(opens sec.gov)
May 44
Amouyal Philippe0001062822-26-000092
SEC(opens sec.gov)
Jun 244
Amouyal Philippe0001628280-25-032885
SEC(opens sec.gov)
Jun 34
Amouyal Philippe0001127602-25-016461
SEC(opens sec.gov)
May 134
Amouyal Philippe0001127602-25-014140
SEC(opens sec.gov)
Jun 244
Amouyal Philippe0001628280-24-029569
SEC(opens sec.gov)
May 134
Amouyal Philippe0001127602-24-015076
SEC(opens sec.gov)
Apr 294
Amouyal Philippe0001127602-24-013553
SEC(opens sec.gov)
Nov 214
Amouyal Philippe0001628280-23-039763
SEC(opens sec.gov)
Nov 144
Amouyal Philippe0001127602-23-027360
SEC(opens sec.gov)
Jun 224
Amouyal Philippe0001628280-23-023150
SEC(opens sec.gov)
May 224
Amouyal Philippe0001127602-23-016428
SEC(opens sec.gov)

Companies

Address

C/O CAVA GROUP, INC. 14 RIDGE SQUARE NW, SUITE 500

WASHINGTON, DC, 20016